Trial Profile
Efficacy of Single inhaler Maintenance And Reliever Therapy (SMART) with Spiromax budesonide/formoterol versus fixed dose treatment with Diskus fluticasone/salmeterol in COPD.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 27 Feb 2015
Price :
$35
*
At a glance
- Drugs Budesonide/formoterol (Primary) ; Salmeterol/fluticasone propionate
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 27 Feb 2015 New trial record